<?php
	// $pageTitle = "Page Title";
	// $description = "Description text here";
	// $keywords = "Keywords here";
	// $activePage = "home";
	
	include("includes/header.php");
?>
    <div class="content">
	
        <section id="home-page-banner" class="home-page-banner">
		<div class="row">
		     <img src="assets/images/banner1.jpg" alt="" class="img-responsive home-banner" / style="margin-top:-43px;    margin-left:15px;">
				<a href=""><button type="button" class="btn btn-danger mybutton" style="position: relative;
            top: 544px;
 margin-left: 288px;
    border-color: #fff;
    background-color: #fff;
    font-color: black;
    background: transparent; font-family: 'AcuminPro-bold', sans-serif;font-weight:700;">DISCOVER THE DIFFERENCE</button></a>
		<a href=""><button type="button" class="btn btn-danger mybutton" style="position: relative;
        top: 544px;
    margin-left: 262px;
    border-color: #fff;
    background-color: #fff;
    font-color: black;
    background: transparent; font-family: 'AcuminPro-bold', sans-serif;font-weight:700;">EXPLORE COVERAGE</button></a>
          
		
			</div>

            <div class="image-caption">
                <div class="container">
                    <div class="row">
                        <div class="col-sm-7 col-md-7 col-lg-7">
                           
                            
                        </div>
                    </div>
             
                </div>
            </div>
        </section>
	<style type="text/css" media="screen">
        

.mybutton {
    background: #fff;
    color: #fff;
    border: 1px solid white;
    border-radius: 20px;
    outline: none;
    padding-left:20px;
    padding-right:20px;  
}
button.btn.btn-danger.mybutton {
    outline: none;
}

.whiteback {
    background-image: url(images/diffrenciation/1.png);
    height: -webkit-fill-available;
    margin-top: 50px;
    margin-left:-30px;
    background-size: 100% 500px;
    background-repeat: no-repeat;

}
    </style>
		 <section id="our-services" class="our-services">
                <div class="container">
                    <div class="row">
					  <div class="col-xs-12 col-sm-3 col-md-2 col-lg-2">
					  </div>
                        <div class="col-xs-12 col-sm-6 col-md-10 col-lg-10">
                            <div class="top-text">
                                <h3 style="    font-weight: 700;
    color: #580f8b;
    font-size: 34px;
    font-family: 'Politica-Black',sans-serif;text align: Center">
								
                                    ON A MISSION TO SAVE MILLION AT RISK </h3>
                                <h4 style="    text-align: center;
    margin-right: 166px;
    color: #2c2c2c;
    float: left;
    margin-left: -95px;font-family: 'AcuminProCond-regular', sans-serif;
    font-size: 28px;font-weight:500;line-height:1.0;">Tetraphase is committed to making novel antibiotics accessible to all patients in need.</h4>
                               <a href=""><h4 style="margin-left: 85px;
    color: #d40072;
    font-size: 28px;"><br><br><br>SEE OUR LATEST DEVELOPMENTS > </h4></a>
                            </div>
                        </div>
						 <div class="col-xs-12 col-sm-3 col-md-2 col-lg-2">
					  </div>
                    </div>
                
                </div>
            </section>
        <!--banner ends -->
     <section id="our-department" class="our-department">
                <div class="container">
               
                    <div class="row">
                        <div class="">
                         
                            <div class="tab-content tab-content col-sm-12 col-md-12  col-lg-12 no-padding">
                                <div class="tab-pane active" id="CARDIOLOGY">
                                    <div class="tab-image">
                                        
                                    <p class="department-para" style="font-size:16px;">
                                       cIAI, complicated intra-abdominal infection.   </p>
									   <p style="font-size:14px;"><b>References: 1.</b> XERAVA [prescribing information]. Watertown, MA: Tetraphase Pharmaceuticals, Inc.; 2018. 2. Zhanel GG, Cheung D, Adam H, et al. Review of eravacycline, a novel fluorocycline antibacterial agent. Drugs. 2016;76:567-588.</p><br><br>
									   
									   <p class="blue">
                                       Indications and Usage </p>
                                
                                    <p class="italic" style="font-family: 'AcuminProCond Italic', sans-serif;">XERAVA is indicated for the treatment of complicated intra-abdominal infections (cIAI) caused by susceptible microorganisms: <i>Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii, Enterobacter cloacae, Klebsiella oxytoca, Enterococcus faecalis, Enterococcus faecium Staphylococcus aureus, Streptococcus anginosus group, Clostridium perfringens, Bacteroides species, and Parabacteroides distasonis in patients 18 years or older.</i></p><br>
									<p><u>Limitations of Use</u></p>
									<p>
XERAVA is not indicated for the treatment of complicated urinary tract infections (cUTI).</p><br>
<p class="blue">Usage</p>
<p class="">To reduce the development of drug-resistant bacteria and maintain the effectiveness of XERAVA and other antibacterial drugs, XERAVA should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.</p><br>
<p class="blue">Important Safety Information</p>
<p>XERAVA is contraindicated for use in patients with known hypersensitivity to eravacycline or to tetracycline-class antibacterial drugs. Life-threatening hypersensitivity (anaphylactic) reactions have been reported with XERAVA.</p><br>
<p>The use of XERAVA during tooth development (last half of pregnancy, infancy and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown) and enamel hypoplasia. </p><br>
<p>The use of XERAVA during the second and third trimester of pregnancy, infancy and childhood up to the age of 8 years may cause reversible inhibition of bone growth.</p><br>
<p><i>Clostridium difficile </i>associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, and may range in severity from mild diarrhea to fatal colitis. </p><br>
<p>The most common adverse reactions observed in clinical trials (incidence â‰¥ 3%) were infusion site reactions (7.7%), nausea (6.5%), and vomiting (3.7%). </p><br>
<p>XERAVA is structurally similar to tetracycline-class antibacterial drugs and may have similar adverse reactions. Adverse reactions including photosensitivity, pseudotumor cerebri, and anti-anabolic action which has led to increased BUN, azotemia, acidosis, hyperphosphatemia, pancreatitis, and abnormal liver function tests, have been reported for other tetracycline-class antibacterial drugs, and may occur with XERAVA.  Discontinue XERAVA if any of these adverse reactions are suspected.</p><br>
<p><b>To report SUSPECTED ADVERSE REACTIONS, contact Tetraphase Pharmaceuticals Inc., at 1-833-7-XERAVA (1-833-793-7282) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</b></p> 
                                </div>
                           
                          
                            </div>
                        </div>
                        <!-- tab content -->
                    </div>
                </div>
            </section>
    </div>
	
   <?php
	// $pageTitle = "Page Title";
	// $description = "Description text here";
	// $keywords = "Keywords here";
	// $activePage = "home";
	
	include("includes/footer.php");
?>